FI109901B - Menetelmä uusien terapeuttisesti käyttökelpoisten bentseenisulfonyyli-imiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten bentseenisulfonyyli-imiinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI109901B
FI109901B FI962235A FI962235A FI109901B FI 109901 B FI109901 B FI 109901B FI 962235 A FI962235 A FI 962235A FI 962235 A FI962235 A FI 962235A FI 109901 B FI109901 B FI 109901B
Authority
FI
Finland
Prior art keywords
formula
compound
dichloro
mmol
acid
Prior art date
Application number
FI962235A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962235A0 (fi
FI962235A (fi
Inventor
David M Stemerick
George Ku
Boyd Lynn Harrison
Christopher Robin Dalton
Scott Burrill Meikrantz
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI962235A0 publication Critical patent/FI962235A0/fi
Publication of FI962235A publication Critical patent/FI962235A/fi
Application granted granted Critical
Publication of FI109901B publication Critical patent/FI109901B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI962235A 1993-11-29 1996-05-28 Menetelmä uusien terapeuttisesti käyttökelpoisten bentseenisulfonyyli-imiinijohdannaisten valmistamiseksi FI109901B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15901493A 1993-11-29 1993-11-29
US15901493 1993-11-29
US9412658 1994-11-03
PCT/US1994/012658 WO1995014669A1 (en) 1993-11-29 1994-11-03 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action

Publications (3)

Publication Number Publication Date
FI962235A0 FI962235A0 (fi) 1996-05-28
FI962235A FI962235A (fi) 1996-05-28
FI109901B true FI109901B (fi) 2002-10-31

Family

ID=22570705

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962235A FI109901B (fi) 1993-11-29 1996-05-28 Menetelmä uusien terapeuttisesti käyttökelpoisten bentseenisulfonyyli-imiinijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US5684017A (hu)
EP (1) EP0731791B1 (hu)
JP (1) JPH09506345A (hu)
KR (1) KR100340375B1 (hu)
CN (1) CN1044116C (hu)
AT (1) ATE177083T1 (hu)
AU (1) AU683114B2 (hu)
CA (1) CA2175458C (hu)
DE (1) DE69416859T2 (hu)
DK (1) DK0731791T3 (hu)
ES (1) ES2131297T3 (hu)
FI (1) FI109901B (hu)
GR (1) GR3029827T3 (hu)
HU (1) HU219565B (hu)
IL (1) IL111776A (hu)
NO (1) NO306211B1 (hu)
NZ (1) NZ276577A (hu)
PT (1) PT731791E (hu)
TW (1) TW279161B (hu)
WO (1) WO1995014669A1 (hu)
ZA (1) ZA949303B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
DE19705133A1 (de) * 1997-02-11 1998-08-13 Hoechst Ag Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU9696198A (en) * 1997-10-17 1999-05-10 Aventis Pharmaceuticals Products Inc. Therapeutic uses of quinoline derivatives
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
JP4212470B2 (ja) 2001-06-26 2009-01-21 アムジェン フレモント インク． Ｏｐｇｌへの抗体
CA2451699A1 (en) * 2001-06-26 2003-01-09 Beth Israel Deaconess Medical Center Compositions and methods for inhibiting platelet activation and thrombosis
CA2511823A1 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
KR100687522B1 (ko) * 2005-05-28 2007-02-27 한국화학연구원 2,2-디메틸-3-에스테르-4-알콕시-6-알킬 아미노벤조피란 유도체를 유효성분으로 함유하는 pge2 활성에 관련된 염증질환 치료제
CN104447489B (zh) * 2014-12-29 2017-01-11 南京工业大学 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents
AU660969B2 (en) * 1991-02-27 1995-07-13 Merrell Pharmaceuticals Inc. NMDA antagonists
AU682736B2 (en) * 1993-11-29 1997-10-16 Merrell Pharmaceuticals Inc. Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action

Also Published As

Publication number Publication date
AU1087995A (en) 1995-06-13
FI962235A0 (fi) 1996-05-28
FI962235A (fi) 1996-05-28
DE69416859T2 (de) 1999-08-05
EP0731791B1 (en) 1999-03-03
HU219565B (hu) 2001-05-28
TW279161B (hu) 1996-06-21
DE69416859D1 (de) 1999-04-08
CN1136311A (zh) 1996-11-20
IL111776A (en) 1999-06-20
GR3029827T3 (en) 1999-06-30
PT731791E (pt) 2000-11-30
DK0731791T3 (da) 1999-09-27
AU683114B2 (en) 1997-10-30
CA2175458C (en) 1999-03-02
IL111776A0 (en) 1995-01-24
JPH09506345A (ja) 1997-06-24
EP0731791A1 (en) 1996-09-18
CN1044116C (zh) 1999-07-14
NO962155D0 (no) 1996-05-28
US5684017A (en) 1997-11-04
ES2131297T3 (es) 1999-07-16
KR960706476A (ko) 1996-12-09
ZA949303B (en) 1995-08-07
HU9601435D0 (en) 1996-07-29
CA2175458A1 (en) 1995-06-01
NO306211B1 (no) 1999-10-04
NZ276577A (en) 1997-11-24
WO1995014669A1 (en) 1995-06-01
KR100340375B1 (ko) 2002-11-13
HUT76273A (en) 1997-07-28
NO962155L (no) 1996-05-28
ATE177083T1 (de) 1999-03-15

Similar Documents

Publication Publication Date Title
FI109901B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bentseenisulfonyyli-imiinijohdannaisten valmistamiseksi
RU2392276C2 (ru) Замещенные аминоалкил- и амидоалкилбензопиранпроизводные
CA2466560A1 (en) Acetylene derivatives having mglur5 antagonistic activity
EP2190837B1 (en) 4-pyrimidinesulfamide derivative
JP2718595B2 (ja) キノキサリン類およびその製法
CZ289787A3 (cs) Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
EP0170213A1 (en) Glutarimide antianxiety and antihypertensive agents
FI67686C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat
EP2344462B1 (en) Pyrimidine derivatives and their pharmaceutical use
US5668143A (en) Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
AU729733B2 (en) Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones
JP3465794B2 (ja) Ｎｍｄａ拮抗剤
KR100276994B1 (ko) 아릴알콕시페녹시-이미다졸린화합물
AU2003301277B2 (en) 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
JPH05213870A (ja) 環式ナイトロン類
IL31508A (en) Antipyretic preparations containing a history of esters of the 4-hydroxy-3-quinoline carboxylic acid esters

Legal Events

Date Code Title Description
MA Patent expired